ABSTRACT
Introduction Although strip packs date from the late 1920s (starting with the single Aspro strip in waxed paper) and blister packs from the early 1960s, both are now well established forms of pharmaceutical 'unit dose' packaging. As unit dose packs offer individual protection until the dose therein is removed, personal dosage, tamper-evidence, child safety, no cross-contamination risks, no opening and reclosing problems, etc., their popularity has limited the growth of typical multipacks. Against these advantages, blisters and strips generally occupy larger volumes than their multipack equivalents. However, this increased pack external area, particularly when cartoned, may enhance the product display image and offer more label space.
